|
Volumn 15, Issue 2, 2009, Pages 179-192
|
Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2'-FLUORO-5-METHYLARABINOSYLURACIL;
ANTIVIRUS AGENT;
CLEVUDINE;
DRUG DERIVATIVE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE;
URACIL ARABINOSIDE;
VIRUS DNA;
ADULT;
AGED;
ANTIVIRAL RESISTANCE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GENETICS;
GENOTYPE;
HEPATITIS B;
HUMAN;
MALE;
MIDDLE AGED;
MUTATION;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIVIRAL AGENTS;
ARABINOFURANOSYLURACIL;
DNA, VIRAL;
DRUG RESISTANCE, VIRAL;
FEMALE;
GENOTYPE;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
MUTATION;
RNA-DIRECTED DNA POLYMERASE;
|
EID: 70350508683
PISSN: 1738222X
EISSN: None
Source Type: Journal
DOI: 10.3350/kjhep.2009.15.2.179 Document Type: Article |
Times cited : (8)
|
References (0)
|